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Developmental dysplasia of the hip (DDH) is the most common congenital 
deformation of the musculoskeletal system and its successful treatment is closely related 
to early diagnosis. 
The study is aimed at examining the incidence of developmental dysplasia of the hip 
(DDH) and at analysing the validity of clinical examination, which is used for the early 
detection of DDH in the neonatal period, compared to ultrasound examination.  
The study involved 400 neonates born in the Banja Luka Region. A new 
questionnaire was open during the first regular ultrasound and clinical examination of 
the neonates’ hips and anamnestic and clinical data were recorded in it: the asymmetry 
of the gluteal, inguinal and femoral folds (Bade sign), the result of abduction test 
separately for each hip, the Ortolani sign of luxation and the Palmen sign of reposition, 
then hip sonography. A Toshiba ultrasound machine with a 7.5 MHz linear probe was 
used. The method employed was Professor Reinhard Graf’s.  
Out of the total number of the children with a positive sonographic finding for DDH, 
63.16% of them have one of the clinical signs of DDH. The ability of a clinical finding to 
identify those patients who do not have DDH and have a negative sonographic finding is 
79.8%. Out of the total number of the examined children with a positive clinical finding, 
only 15.58% of them also have a positive sonographic finding for DDH.   
This research has showed that clinical examination of the hips is of low sensitivity, 
specificity and reliability, and that not all types of DDH can be detected. Clinical 
examination must remain an integral part of every infant’s examination, but it 
constitutes a complementary diagnostic procedure to ultrasound examination.  The 
ultrasound examination of DDH has created new possibilities and has filled the void that 
existed due to the deficiency of clinical tests, and at the same time it has reduced the 
number of X-ray examinations of the hips.  
This research has confirmed that clinical examination of the hips does not meet the 
screening criteria. It must remain an integral part of an infant’s examination because it, 
among other things, provides the information which enables the orthopaedic surgeon to 
choose the most beneficial therapeutic procedures in DDH treatment. Acta Medica 
Medianae 2011;50(1):26-31.  
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Introduction 
 
 
Developmental dysplasia of the hip (DDH) 
is the most common congenital deformation of 
the musculoskeletal system and its successful 
treatment is closely related to early diagnosis 
(1). The commencement, duration and intensity 
of the effects of the causative factors directly 
influence the level of morphological, anatomical 
and biomechanical changes in the hip. The primary 
causative factors and secondary morphological 
changes are reversible. Therefore, the modern 
concept of the health care of children must be 
directed to early detection and timely application 
of the most effective preventive and therapeutic 
procedures (2).   
The treatment results are better if the 
deformation is identified immediately after the 
child’s birth and such preventive or therapeutic 
procedures are prescribed that provide physio-
logical development of the hip joint. DDH treatment 
that commences in the neonatal period lasts 3 - 4 
m o n t h s  w i t h  a  g o o d  c h a n c e  o f  f u l l  r e c o v e r y .  
Employing therapeutic procedures from the third 
month of life requires a treatment the length of 
which is minimum 9 months, with a still good 
prognosis for recovery (3, 4). Starting early with 
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of the treatment allows the use of the physio-
logical potential for the growth and development 
of the hip joint, so that the therapeutic proce-
dures are simpler, take less time, and result in 
the lessening of the need for surgical inter-
ventions (5), which all together significantly 
reduces the treatment costs (6). 
Diagnostic procedures used nowadays are 
based on clinical, ultrasound and radiological 
examinations of the hips (7). 
Clinical examination is a subjective diagnostic 
procedure that depends on the knowledge, skill and 
experience of the examiner. Clinical examination 
of the hips can, with experience, only partially 
diagnose the subluxation and luxation of the hip, 
while dysplasia remains undetected (7). 
Radiological diagnostics is inappropriate for 
routine application because, in addition to the 
damaging effects of radiation, it cannot show all 
morphological structures of the hip joint at the 
age of up to 4 months of the newborn. CT scan 
and magnetic resonance are diagnostic methods, 
inappropriate as the method of choice when 
diagnosing DDH (8). 
X-ray examination is not a reliable diagnostic 
instrument in the first four months of life, when 
ossification is still in its early stages. It shows 
only the ossified parts of the skeleton and, 
moreover, there are damaging effects of ionising 
radiation (9).  
Ultrasound diagnostics has forced itself as 
the method of choice in diagnosing all types of 
DDH immediately after a child’s birth. It is easy 
to perform, harmless and it gives neither false-
positive nor false-negative test results (10). 
Ultrasound examination of the hips, which may 
be performed as early as in the first days of life, 
is an objective method of high sensitivity and 
sensibility. This method holds a very important 
place in children’s orthopaedics as it allows visual 
assessment of the hip joint, especially the 
cartilage part of the acetabular roof and the 
proximal part of the femur, which do not show on 
the radiograph in the neonatal period. Graf and 
Harcke’s examination techniques are the most 
common ultrasound examination techniques for 
the hips in the world and are the major 
representatives of different approaches to DDH 
classification (11). 
Clinical examination and taking X-ray of the 
hips have been tried as diagnostic procedures in 
DDH examination and have not given the expected 
results in performing regular examinations (12). 
Basically, clinical knowledge and skills in 
the ultrasound application of the Graf method 
have become the primary factor for the exami-
nation, early detection and application of the most 
effective (13) preventive and therapeutic procedures 
in DDH. 
 
Aim 
 
This study is aimed at examining the 
incidence of DDH and analysing the validity of 
clinical examination, which is used for the early 
detection of DDH in the neonatal period, 
compared to ultrasound examination.  
The aim is to verify that ultrasound exami-
nation is the method of choice in diagnosing 
developmental dysplasia of the hip joint and the 
only diagnostic procedure that meets the exami-
nation/screening criteria. 
 
Material and methods 
 
The patients are 400 neonates born in the 
Banja Luka Region and examined in the 
orthopaedic surgery in the period between   
August 1, 2010 and  November 1, 2010. 
A questionnaire was open during the first 
regular hip examination of the newborns in the 
orthopaedic surgery and the data used for 
statistical processing were recorded in it. Only 
the children who were less than 45 days old 
during the first examination were assigned in this 
group. The newborn was examined clinically after 
anamnestic data were taken from the parents.   
The data on the asymmetry of the gluteal, 
inguinal and femoral folds (Bade sign), the result 
of abduction test separately for each hip, the 
Ortolani sign of luxation and the Palmen sign of 
reposition had to be recorded in the section of 
the questionnaire envisaged for the clinical 
examination of the hips.  
The hip sonography followed the clinical 
examination. A Toshiba ultrasound machine with 
a 7.5 MHz linear probe was used. The method 
employed was Professor Reinhard Graf’s. 
Sensitivity – Sn, specificity – Sp, positive 
predictive value – PPV, negative predictive value 
– NPV, prevalence – pre-test probability – P, 
likelihood ratio LR ( positive (LR+) and negative 
(LR-)) and post-test probability – PTP were taken 
into account in order to assess the reliability and 
validity of clinical examination compared to 
ultrasound findings (treated as ‘gold standard’). 
The so-called diagnostic table was created 
for the research needs and it was basically a 2x2 
contingency table where the patients were 
classified as follows: 
-  compared to the reference method 
(sonographic finding) – table columns: the first 
column containing the patients with DDH present 
and the second column containing the patients 
with no DDH; 
-  compared to the examined diagnostic 
method (clinical finding) – table rows: the first 
row containing the patients with a positive clinical 
finding for DDH and the second row containing 
the patients with a negative clinical finding for 
DDH. 
The diagnostic table defined in this way 
provides four DDH values: a (positive ultrasound 
finding), b (negative ultrasound finding), c 
(negative clinical finding), and d (positive clinical 
finding). The sum of ‘a’ and ‘b’ is the number of 
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sum of ‘c’ and ‘d’ is the number of patients with a 
negative clinical finding. Table 1 was made on 
the basis of the definition of the parameters used 
for assessing the validity and reliability of the 
clinical finding compared to the gold standard 
(sonographic finding) in diagnosing developmental 
dysplasia of the hip (DDH). 
 
Table 1: Contingency table model for calculating the 
sensitivity (Sn), specificity (Sp), positive predictive 
value (PPV) and negative predictive value (NPV) of DDH 
diagnostic methods. 
 
Sonographic finding  Contingency 
table  
Finding 
Positive Negative  Total 
Positive a  b  a+b 
Negative c  d  c+d 
Clinical 
finding 
Total   a+c  b+d  a+b+c+d 
  
  Results 
 
The results obtained are given in a table 
format (Tables 2 to 5) and they represent the so-
called diagnostic contingency tables which show the 
results of the clinical finding: Bade sign, abduction 
test and the two clinical signs combined, 
respectively.  
 
Table 2: Contingency table (diagnostic table) for clinical 
finding 
 
Sonographic finding  Contingency 
table  
Finding 
Positive Negative  Total 
Positive 12  65  77 
Negative 7  316  323 
Clinical 
finding 
Total   19  381  400 
 
Table 3: Contingency table (diagnostic table) for Bade 
sign 
 
Sonographic finding  Contingency 
table  
Finding 
Positive Negative  Total 
Positive 6  57  63 
Negative 13  324  337  Bade sign 
Total   19  381  400 
 
Table 4: Contingency table (diagnostic table) for 
abduction test 
 
Sonographic finding  Contingency 
table  
Finding 
Positive  Negative Total 
Positive 8  14  22 
Negative 11  367  378 
Abduction 
test 
Total   19  381  400 
Table 5: Contingency table (diagnostic table) for the 
two clinical signs combined 
 
Sonographic finding  Contingency 
table  
Finding 
Positive  Negative Total 
Positive 4  6  10 
Negative 15  375  390 
Two clinical 
signs 
combined 
Total   19  381  400 
 
  Individual parameters of reliability and 
validity are calculated on the basis of the diagnostic 
tables and that is shown in Summary Table 6.  
It may be concluded on the basis of the 
obtained parameters that the sensitivity (Sn) of the 
Bade sign amounts to 31.58%, of the abduction 
test to 42.11%, of the two clinical signs combined 
to 21.05% and of the total clinical finding to 
63.16%. Out of the total number of the children 
with a positive sonographic finding for DDH, 
63.16% of them had positive results in the clinical 
examination too. The ability of the clinical finding to 
identify patients with a positive sonographic finding 
amounts to 63.16%. In view of the fact that 
orthopaedic examinations were performed by highly 
experienced orthopaedic surgeons, it may be 
concluded that the sensitivity of the clinical finding 
is moderately low. Any result exceeding 90% may 
be considered very high and acceptable for a 
diagnostic method. As for the sensitivity of the 
individual clinical signs and the sensitivity of the 
two clinical signs combined, the results show they 
are below 50%. That suggests that the clinical signs 
by themselves do not suffice to detect DDH.  
On the basis of the obtained specificity (Sp) 
of the Bade sign (14.96%), abduction test (3.67%), 
two clinical signs combined (1.57%) and total 
clinical finding (20.2%), we conclude that 79.8% 
have a negative clinical finding. The ability of the 
clinical finding to identify the patients with no DDH 
and with a negative sonographic finding is 79.8%. 
This suggests that the clinical signs by themselves 
do not suffice to diagnose DDH.  
Positive predictive value (PPV) is the 
probability (percentage) of patients with positive 
clinical and sonographic fin d i n g s  f o r  D D H .  O n  t h e  
basis of the obtained positive predictive value of the 
Bade sign (9.52%), abduction test (36.36%), two 
clinical signs combined (40.00%) and total clinical 
finding (15.58%), we conclude that out of the total 
number of the children with a positive clinical 
finding only 15.58% of them have a sonographic 
finding for DDH, too. As for the positive predictive 
value of the individual clinical signs and the positive 
predictive value of the two signs combined, the 
results show they are below 50%. That suggests 
that the clinical signs by themselves do not suffice 
to detect those patients who really have a positive 
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Table 6: Summary diagnostic parameters 
Dijagnostički parametar 
Badeov 
znak 
Abdukcioni 
test 
Udružena dva 
klinička 
znaka 
Klinički 
nalaz 
Senzitivnost 0,3158  0,4211  0,2105  0,6316 
Specifičnost 0,1496  0,0367  0,0157  0,8294 
Pozitivna prediktivna vrijednost  0,0952  0,3636  0,4000  0,1558 
Negativna prediktivna vrijednost  0,9614  0,9709  0,9615  0,9783 
Prevalenca 0,0475  0,0475  0,0475  0,0475 
Odnos vjerodostojnosti pozitivnog rezultata  0,3713  0,4371  0,2139  3,7020 
Odnos vjerodostojnosti negativnog rezultata  4,5734  15,7556  50,1316  0,4442 
Vjerovatnoća-poslije dijagnostičke metode (LR+)  0,8816  0,8976  0,8109  0,9867 
Vjerovatnoća-poslije dijagnostičke metode (LR-)  0,9892  0,9968  0,9990  0,8991 
 
Negative predictive value (NPV) is the 
percentage of patients with negative clinical and 
sonographic findings for DDH. On the basis of the 
obtained negative predictive value of the Bade sign 
(96.14%), abduction test (97.09%), two clinical 
signs combined (96.15%) and total clinical finding 
(97.83%), we conclude that out of the total number 
of the children with a negative clinical finding 
97.83% of them have a negative sonographic 
finding for DDH. As for the negative predictive 
value of the individual clinical signs and the 
negative predictive value for the two signs 
combined, the results show they are above 90%. 
That suggests that the clinical signs by themselves 
do not suffice to detect those patients who have a 
negative sonographic finding.  
Prevalence (P) or clinical pre-test probability 
is the percentage of patients who really have a 
positive sonographic finding. On the basis of the 
obtained prevalence of the Bade sign (4.75%), 
abduction test (4.75%), two clinical signs combined 
(4.75%) and total clinical finding (4.75%), the DDH 
prevalence in our case amounts to 4.75%. 
It follows from the obtained likelihood ratio 
positive (LR+) of the clinical examination, for the 
Bade sign (0.3713), abduction test (0.4371), two 
clinical signs combined (0.2139) and total clinical 
finding (3.7020), that it is almost four times (more 
precisely 3.7020) more likely that, compared to 
children with a negative sonographic finding, a child 
with a positive sonographic finding will have a 
positive result of clinical examination. As for the 
likelihood ratio of the individual clinical signs and 
the likelihood ratio of the two signs combined, the 
results show they are far below 1, i.e. that the 
probability that a positive result came from a 
patient with DDH is low for the individual clinical 
signs.  
Likelihood ratio negative (LR-) is the 
reliability that the negative test result of a clinical 
examination came from a child that really has DDH. 
It may be concluded on the basis of the obtained 
likelihood ratio negative for clinical examination 
(0.4442) that the probability that a child that really 
has DDH will be identified as healthy during a 
clinical examination is low. As for the likelihood 
ratio of the clinical signs, Bade sign (4.5734), 
abduction test (15.7556), two clinical signs 
combined (50.1316), the results show they are far 
above 1, i.e. that the probability that a negative 
result came from a patient with no DDH is low, 
which supports the reliability of the clinical signs in 
identifying those patients who really do not have 
DDH.  
 
Discussion 
 
Clinical examination must remain an integral 
part of every infant’s examination, but as a 
complementary diagnostic procedure to ultrasound 
examination (14). Advances in medicine, especially 
technological ones, have created new possibilities 
and have filled the void that existed due to the 
deficiency of clinical tests, and at the same time 
they have reduced the number of X-ray exami-
nations of the hips. The progress has been made 
due to the application of ultrasound (15). 
Past experiences with the application of 
ultrasound in developmental dysplasia of the hip 
have showed that ultrasound can be applied in 
screening as well (4-15). Ultrasound can detect all 
types of developmental dysplasia of the hip as early 
as in the maternity ward, and repeated ultrasound 
examinations at certain intervals may separate 
those hips that are developing normally from those 
that are developing subluxations and luxations.   
DDH incidence varies and it ranges widely 
from 2 to 50, and higher, per 1000 births (2, 3). 
The great difference in the prevalence is the 
result of non-uniform terminology, size of the 
examined population, ethnic features, child’s age 
at the time of examination, examiner’s experience, 
examination technique, and interpretation of the 
results obtained. The incidence is lowest in Hong 
Kong (0.01%), then in Nothern Ireland (0.14%), 
Sweden (0.17%), America (between 0.2% and 
0.4%), and in Great Britain it amounts to about 
1.5% (9). According to Vrdoljak and Matasović’s 
reports, the screening results for DDH in Croatia 
show that the incidence stands around 2%, 
although there are regions where it amounts to as 
little as 0.2% but also as much as 4%. The DDH 
incidence in Serbia has in recent years stood 
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w e r e  c l i n i c a l l y  e x a m i n e d  b y  u l t r a s o u n d  a t  t h e  
Neonatal Department of the Gynaecology and 
Obstetrics Clinic in Novi Sad and at the Banjica 
Institute for Orthopaedic Surgery in Belgrade and 
the DDH incidence established amounted to 1.95%. 
The incidence of developmental dysplasia of 
the hip established on the basis of clinical 
examination varies in the available bibliography 
between 1.66% (Barlow) and 40% (Soć, Brecelj). 
This data does not only depend on the examiner, 
but also on the region and time in which the 
research was conducted, as well as on the age of 
the children at the time of the hip examination. In 
the 1960’s, Šoć and Brecelj conducted DDH 
researches in Donja Zeta and found that the DDH 
prevalence was higher than 40%. At the same 
time, Barlow presented completely opposite data 
and stated a very low DDH incidence rate. He 
examined children at birth and then followed 
them until they were 4 months old and he came 
to the conclusion that 60% of the hips that were 
unstable at birth stabilised in the first week, and 
88% in the next 2 months. The remaining 12% 
had residual instability. The given data suggests 
that performing only a clinical examination is an 
insufficient and unreliable DDH screening method, 
but it needs to be performed as part of the 
examination of a child’s hips.  
Our clinical examination detected 59 
(19.33%) children in the examined sample with 
some of the clinical signs of DDH.  51 children had 
only one positive clinical sign, specifically 41 
(13.66%) had a positive Bade sign, 9 (3.00%) had 
a positive abduction test, and 1 (0.33%) had 
positive Ortolani and Palmen signs. 8 (2.66%) 
children had a positive Bade sign and abduction 
test. The other 241 (80.33%) children did not have 
a single clinical sign of DDH. The first sonographic 
examination of the children in the examined sample 
detected DDH in 13 children (4.33%), specifically in 
9 (69.23%) females and 4 (30.76%) males. In 3 
(23.07%) it was a bilateral malformation and in 10 
(76.92) a unilateral malformation. In total, 16 
diseased hips, 8 right and 8 left, were detected.   
The data on the prevalence of DDH is very 
variable. In Croatia, the prevalence of DDH ranges 
between 2 and 4.3% (2). In Sweden, it amounts to 
1.7 per 1000, while in BiH the prevalence of some 
DDH type is the highest in Europe and it amounts 
to 75 newborns per 1000 (3). Skokić et al. state, 
based on ultrasound examinations, that the 
prevalence of DDH in Tuzla amounts to 8.86% in 
the risk group, while it amounts to 48 per 1000 live 
births in the general population (4). These results 
show a somewhat higher prevalence in comparison 
with previous researches conducted in Tuzla, when 
DDH incidence amounted to 6.31% (5). 
This research has showed that clinical 
examination of the hips is of low sensitivity, 
specificity and reliability, and that it cannot detect 
all types of DDH. Still, even such concept has 
yielded significant results, but a greater number of 
children with DDH were detected only after the 
fourth month of life and later, when the diagnosis 
was confirmed by the x-ray of the hips (14).   
Past experiences with the application of 
ultrasound in DDH have showed that ultrasound 
can be applied in screening (4, 5). Ultrasound can 
detect all types of DDH as early as in the maternity 
ward, and repeated ultrasound examinations at 
certain intervals may separate those hips that are 
developing normally from those that are developing 
subluxations and luxations (5). Opinions on 
screening are still divided nowadays: some think 
that selective screening is completely sufficient (5, 
6), while others are in favour of non-selective 
screening (4,10). Those in favour of selective 
screening feel that non-selective screening is 
impractical, costly and results in iatrogenous 
lesions during the treatment. We agree with 
those supporting non-selective screening because 
it is warranted in those countries where incidence 
is high. DDH, as a disease, meets the screening 
criteria, and ultrasound is the most compre-
hensive diagnostic method that meets the criteria 
for performing screening. Clinical and ultrasound 
examinations are nowadays used as screening 
tests for this disorder. The importance of ultra-
sound screening of the hips in the neonatal period 
is more and more stressed nowadays, so that DDH 
can be diagnosed in as many as 30% of children  
with primarily stable hips.  
 
Conclusion 
 
Analysing the incidence of DDH and establi-
shing the deficiencies of clinical examination in 
detecting DDH requires taking urgent measures 
with a view to early detecting and treating this 
disorder.   
This research has confirmed that the clinical 
examination of the hips does not meet the 
screening criteria. It must remain an integral part 
of an infant’s examination because it, among other 
things, provides the information which allows the 
orthopaedic surgeon to choose the most beneficial 
therapeutic procedures in treating DDH. 
If one transfers the concept of secondary 
prevention to DDH diagnostics, then the ultrasound 
screening of the hips should be accepted in the 
national programme for the prevention of this 
disorder as a mandatory examination of a newborn.  
Ultrasound diagnostics is the method of 
choice for the non-selective screening for DDH.  
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POUZDANOST I VALIDNOST KLINIČKOG I ULTRAZVUČNOG 
PREGLEDA RAZVOJNOG POREMEĆAJA KUKA 
 
Predrag Grubor, Rade Tanjga
 i Milan Grubor 
 
 
  Razvojni poremećaj kuka (RPK) najčešća je urođena deformacija lokomotornog 
sistema, čiji je uspijeh liječenja usko povezan s ranom dijagnozom. 
Cilj rada bio je da se ispita incidencija razvojnog poremećaja kuka (RPK) i analizira 
validnost kliničkog pregleda koji se koristi za rano otkrivanje RPK u neonatalnom periodu 
u odnosu na ultravučni pregled. 
Ispitanike  čine 400 novorođene djece rođene u banjalučkom regionu. Prilikom 
redovnog prvog ultrazvučnog i kliničkog pregleda kukova novorođenčadi otvarao se 
anketni listić u koji su unošeni anamnestički i klinički podaci: asimetrija glutealnih, 
ingvinalnih i femoralnih brazda (Badeov znak), rezultat abdukcionog testa posebno za 
svaki kuk, Ortolanijev luksacioni i Palmenov repozicioni znak, potom sonografija   
kukova. Korišćen je ultrazučni aparat marke “Toshiba” sa linearnom sondom od 7,5 MHz. 
Primjenjivana je metoda po prof. Reinhard-u Graf-u. 
Od ukupnog broja djece koja  imaju pozitivan sonografski nalaz RPK, njih 63,16% 
ima  jedan od kliničkih znakova RPK. Sposobnost kliničkog nalaza da identifikuje one 
bolesnike koji nemaju RPK i imaju negativan sonografski nalaz, iznosi 79,8%. Od 
ukupnog broja ispitane djece koja imaju pozitivan klinički nalaz, samo 15,58% ima i 
sonografski pozitivan  nalaz  RPK. 
Ovo istraživanje pokazalo je da je klinički pregled kukova niske senzitivnosti, 
specifičnosti i pouzdanosti i da se ne mogu otkriti svi oblici RPK. Klinički pregled mora i 
dalje ostati sastavni dio pregleda svakog dojenčeta, ali  komplementarni dijagnostički 
postupak obavlja se ultrazvučnim pregledom. Ultrazvučni pregled RPK otvorio je nove 
mogućnosti i popunio prazninu koja je bila prisutna u nedostacima kliničkih testova, a 
ujedno smanjio broj rendgenskih pregleda kukova.  
Ovo istraživanje je potvrdilo da klinički pregled kukova ne zadovoljava kriterijume 
za skrining. On i dalje mora ostati sastavni dio pregleda dojenčeta, jer između ostalog, 
pruža informaciju koja ortopedu omogućava najpovoljniji izbor terapeutskih postupaka u 
liječenju RPK. Acta Medica Medianae 2011;50(1):26-31.  
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